Concepedia

Publication | Open Access

Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial

27

Citations

24

References

2015

Year

Abstract

ISRCTN 32207582.

References

YearCitations

Page 1